• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses

tetano

Editor, Senior Moderator
PLoS Pathog


. 2024 Aug 15;20(8):e1012453.
doi: 10.1371/journal.ppat.1012453. Online ahead of print. Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses

Karlijn van der Straten[SUP] 1 2 [/SUP], Denise Guerra[SUP] 1 2 [/SUP], Gius Kerster[SUP] 1 2 [/SUP], Mathieu Claireaux[SUP] 1 2 [/SUP], Marloes Grobben[SUP] 1 2 [/SUP], Angela I Schriek[SUP] 1 2 [/SUP], Anders Boyd[SUP] 3 4 [/SUP], Jacqueline van Rijswijk[SUP] 1 2 [/SUP], Khadija Tejjani[SUP] 1 2 [/SUP], Dirk Eggink[SUP] 1 2 5 [/SUP], Tim Beaumont[SUP] 1 2 [/SUP], Steven W de Taeye[SUP] 1 2 [/SUP], Godelieve J de Bree[SUP] 2 6 [/SUP], Rogier W Sanders[SUP] 1 2 7 [/SUP], Marit J van Gils[SUP] 1 2 [/SUP]



Affiliations
Abstract

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by human sera is a strong correlate of protection against symptomatic and severe Coronavirus Disease 2019 (COVID-19). The emergence of antigenically distinct SARS-CoV-2 variants of concern (VOCs) and the relatively rapid waning of serum antibody titers, however, raises questions about the sustainability of serum protection. In addition to serum neutralization, other antibody functionalities and the memory B cell (MBC) response are suggested to help maintaining this protection. In this study, we investigate the breadth of spike (S) protein-specific serum antibodies that mediate effector functions by interacting with Fc-gamma receptor IIa (FcγRIIa) and FcγRIIIa, and of the receptor binding domain (RBD)-specific MBCs, following a primary SARS-CoV-2 infection with the D614G, Alpha, Beta, Gamma, Delta, Omicron BA.1 or BA.2 variant. Irrespectively of the variant causing the infection, the breadth of S protein-specific serum antibodies that interact with FcγRIIa and FcγRIIIa and the RBD-specific MBC responses exceeded the breadth of serum neutralization, although the Alpha-induced B cell response seemed more strain-specific. Between VOC groups, both quantitative and qualitative differences in the immune responses were observed, suggesting differences in immunogenicity. Overall, this study contributes to the understanding of protective humoral and B cell responses in the light of emerging antigenically distinct VOCs, and highlights the need to study the immune system beyond serum neutralization to gain a better understanding of the protection against emerging variants.


 
Back
Top Bottom